Exemestane Tablet, Sugar Coated
Product Images NDC 59762-2858

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 59762-2858). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Exemestane 01)

FDA Label Image

Figure 1 (Exemestane 02)

Figure 1 (Exemestane 02)
This text provides statistical information about a clinical trial comparing exemestane and tamoxifen treatments for disease-free survival in patients. The hazard ratio (HR) and confidence interval (95% CI) are given, as well as the p-value calculated using the log-rank test. The graph shows the duration of disease-free survival in months for both treatment groups.*
FDA Label Image

Figure 2 (Exemestane 03)

FDA Label Image

Logo (Exemestane 04)

Logo (Exemestane 04)
This is a description of Greenstone brand. The brand is distributed by Greenstone LLC located in Peapack, NJ 07977.*
FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Principal Display Panel (25 mg Tablet Bottle Label)
This is a prescription drug labeled as exemestane tablets, with a National Drug Code (NDC) of 50762-2858-1 and a quantity of 30 tablets. It should be stored at controlled room temperature and distributed by Greenstone LLC located in Peapack, NJ. The dosage and usage details are not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.